Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Harvard Business School
Merck
AstraZeneca
Boehringer Ingelheim
Moodys

Last Updated: December 3, 2022

Haloperidol - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What are the generic sources for haloperidol and what is the scope of patent protection?

Haloperidol is the generic ingredient in six branded drugs marketed by Ortho Mcneil, Ortho Mcneil Pharm, Actavis Group, Cycle Pharms Ltd, Duramed Pharms Barr, Innogenix, Lederle, Mylan, Par Pharm, Purepac Pharm, Quantum Pharmics, Royce Labs, Sandoz, SCS, Strides Pharma, Upsher Smith Labs, Watson Labs, Zydus Pharms Usa, Janssen Pharms, Fresenius Kabi Usa, Gland Pharma Ltd, Hikma, Hospira, Meitheal, Mylan Labs Ltd, Sandoz Inc, Somerset Theraps Llc, Teva Pharms Usa, Zydus Pharms, Alpharma, Lannett Co Inc, Morton Grove, Pharm Assoc, Teva, Teva Pharms, Abraxis Pharm, Akorn, Baxter Hlthcare Corp, Fosun Pharma, Marsam Pharms Llc, Sagent Pharms, Smith And Nephew, Solopak, and Actavis Mid Atlantic, and is included in one hundred and nine NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty drug master file entries for haloperidol. Nineteen suppliers are listed for this compound.

Drug Prices for haloperidol

See drug prices for haloperidol

Drug Sales Revenue Trends for haloperidol

See drug sales revenues for haloperidol

Recent Clinical Trials for haloperidol

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Cancer Prevention Research Institute of TexasPhase 2/Phase 3
Lake Erie College of Osteopathic MedicinePhase 3
Mercy Health OhioPhase 3

See all haloperidol clinical trials

Pharmacology for haloperidol
Medical Subject Heading (MeSH) Categories for haloperidol

US Patents and Regulatory Information for haloperidol

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs HALOPERIDOL haloperidol lactate INJECTABLE;INJECTION 070714-001 May 17, 1988 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Royce Labs HALOPERIDOL haloperidol TABLET;ORAL 072121-001 Dec 24, 1987 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Innogenix HALOPERIDOL haloperidol TABLET;ORAL 071173-004 Jan 2, 1987 AB RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Upsher Smith Labs HALOPERIDOL haloperidol TABLET;ORAL 211061-002 Jan 8, 2020 AB RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Royce Labs HALOPERIDOL haloperidol TABLET;ORAL 071723-001 Dec 24, 1987 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Ortho Mcneil HALDOL haloperidol TABLET;ORAL 015921-005 Approved Prior to Jan 1, 1982 DISCN Yes No See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for haloperidol

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Ortho Mcneil HALDOL haloperidol TABLET;ORAL 015921-001 Approved Prior to Jan 1, 1982 See Plans and Pricing See Plans and Pricing
Ortho Mcneil HALDOL haloperidol TABLET;ORAL 015921-004 Approved Prior to Jan 1, 1982 See Plans and Pricing See Plans and Pricing
Ortho Mcneil HALDOL haloperidol TABLET;ORAL 015921-006 Feb 2, 1982 See Plans and Pricing See Plans and Pricing
Ortho Mcneil HALDOL haloperidol TABLET;ORAL 015921-005 Approved Prior to Jan 1, 1982 See Plans and Pricing See Plans and Pricing
Ortho Mcneil HALDOL haloperidol TABLET;ORAL 015921-003 Approved Prior to Jan 1, 1982 See Plans and Pricing See Plans and Pricing
Ortho Mcneil HALDOL haloperidol TABLET;ORAL 015921-002 Approved Prior to Jan 1, 1982 See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Baxter
Merck
AstraZeneca
Harvard Business School
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.